Articles
Waters and Becton Dickinson Merger Projected to Yield Significant Synergy and Earnings Growth
William Blair Assigns Outperform Rating on Waters Citing Strategic Merger Benefits and Robust Market Position
William Blair has initiated coverage on Waters Corporation following its July 2025 merger agreement with Becton, Dickinson and Company's Biosciences &...
Arthur Hayes Highlights Trump’s Gas Price Strategy as Crucial for Bitcoin’s 2026 Trajectory
BitMex co-founder explains how President Trump’s approach to Venezuela and gas prices could shape Bitcoin’s future
Arthur Hayes, co-founder of BitMex and a prominent Bitcoin advocate, has analyzed the potential impact of President Trump’s strategy involving Venez...
Johnson & Johnson Reports Encouraging Phase 2b Trial Outcomes for Lupus Drug Nipocalimab
Positive data from JASMINE study supports advancement to Phase 3 trials targeting systemic lupus erythematosus
Johnson & Johnson announced results from its Phase 2b JASMINE clinical trial assessing nipocalimab for systemic lupus erythematosus (SLE). The study a...
Anheuser-Busch InBev Commits $30 Million to Enhance Jacksonville Brewing Capacity
Expansion Focuses on Rising Demand for Popular Brands Including Michelob ULTRA
Anheuser-Busch InBev announced a $30 million investment aimed at upgrading brewing and packaging capabilities at its Jacksonville, Florida facility. T...
Meta Delays International Release of Ray-Ban Smart Glasses Due to High US Demand
Strong domestic orders push Meta to postpone global availability of its AI-integrated eyewear
Meta Platforms Inc. has announced a pause on the planned international launch of its Ray-Ban Display smart glasses. Initially slated for early 2026 ro...
Vanda Pharmaceuticals Receives FDA Nod for Nereus Motion Sickness Drug, Analysts Adjust Targets
New treatment breaks four-decade drought in pharmacologic options for motion sickness, spurring varied analyst responses
Vanda Pharmaceuticals has secured FDA approval for Nereus (tradipitant), marking the first new motion sickness medication in more than 40 years. Suppo...
Pepe Cryptocurrency Outperforms Dogecoin and Shiba Inu With 55% Weekly Surge
Market Dynamics and Trader Insights Shed Light on Pepe's Recent Rally
Over the last week, Pepe cryptocurrency (PEPE) has experienced a remarkable ascent of approximately 55%, outpacing prominent meme coins such as Dogeco...
Evaluating AI-Focused ETFs: What Investors Should Consider for 2026
A Detailed Look at AI ETF Purity and Weighting Approaches to Inform Portfolio Decisions
Investor enthusiasm for artificial intelligence stocks remains strong as 2026 begins, with surveys indicating a widespread intention to sustain or inc...
Grab Holdings Advances AI Integration to Transform Southeast Asian Mobility and Delivery
Strategic acquisitions and regulatory approvals propel Grab's autonomous capabilities and digital services expansion
Grab Holdings Limited has been actively advancing its position in the artificial intelligence sector to enhance its core services including ride-haili...
KLX Energy: A High-Risk, High-Reward Long — Backing a Turnaround as Onshore Activity Stabilizes
Operational cash flow recovery + Northeast focus, but heavy leverage keeps this a tactical trade
KLX Energy (KLXE) is cheap on headline price but carries meaningful balance-sheet risk. Recent quarters show improving operating cash flow and stabili...
Washington Commanders Overhaul Coaching Staff After Disappointing Season
Offensive and defensive coordinators Kliff Kingsbury and Joe Whitt Jr. depart alongside offensive line coach Bobby Johnson following a 5-12 record
Following a challenging 5-12 season for the Washington Commanders, head coach Dan Quinn's staff has undergone significant changes. Offensive coordinat...
STAAR Surgical and Alcon Merger Proposal Rejected by Shareholders, STAAR to Continue Independently
Failed shareholder vote leads to termination of merger agreement with no fees payable, as STAAR refocuses on growth and operational efficiencies
STAAR Surgical Company announced its merger agreement with Alcon Inc. was not approved by shareholders during a special meeting. Consequently, STAAR p...